Overview of Potential Side Effects and Management of Brigatinib/Brigatinib

Brigatinib is a targeted drug used to treat non-small cell lung cancer that targets specific cancer cell receptors and is designed to slow cancer progression. However, like other drugs, brigatinib may cause some adverse reactions during use. The following is a detailed introduction to its common adverse reactions:

First, digestive system adverse reactions are more common in patients taking brigatinib. Nausea is one of the most common symptoms, and many patients will experience varying degrees of nausea in the early stages of taking the drug. In addition, some patients may experience fatigue and diarrhea. These symptoms are usually most noticeable within a week or two after starting the medication, but over time, most patients' bodies adapt and symptoms lessen.

In addition to digestive symptoms, brigatinib may also cause some serious adverse reactions. For example, some patients may experience elevated lipase concentrations, which may require further medical testing to determine the cause. Dyspnea and high blood pressure are also serious side effects. The occurrence of these symptoms needs to be reported to the doctor in time so that the doctor can adjust the treatment plan according to the specific situation.

In addition, there are some rarer adverse reactions, such as changes in vision. Patients may experience symptoms such as blurred vision, double vision, or sensitivity to light while taking brigatinib. Although these symptoms are uncommon, once they occur, they should be reported to a doctor immediately for prompt treatment.

In response to these adverse reactions, doctors will develop personalized treatment plans based on the patient's specific conditions. For example, for patients with nausea and vomiting, doctors may recommend some antiemetic medications or adjust the timing of taking them to reduce symptoms. For people with difficulty breathing and high blood pressure, doctors may adjust medication doses or add other treatments to control these symptoms.